Corrigendum to "Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study" [Eur. J. Radiol. Open 11 (2023) 100529].
Publication
, Journal Article
Velaga, J; Tay, KJ; Hang, G; Tan, YG; Yuen, JSP; Chua, MLK; Gupta, RT; Polascik, TJ; Ngo, NT; Law, YM
Published in: Eur J Radiol Open
June 2024
[This corrects the article DOI: 10.1016/j.ejro.2023.100529.].
Duke Scholars
Published In
Eur J Radiol Open
DOI
ISSN
2352-0477
Publication Date
June 2024
Volume
12
Start / End Page
100556
Location
England
Citation
APA
Chicago
ICMJE
MLA
NLM
Velaga, J., Tay, K. J., Hang, G., Tan, Y. G., Yuen, J. S. P., Chua, M. L. K., … Law, Y. M. (2024). Corrigendum to "Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study" [Eur. J. Radiol. Open 11 (2023) 100529]. Eur J Radiol Open, 12, 100556. https://doi.org/10.1016/j.ejro.2024.100556
Velaga, Jyothirmayi, Kae Jack Tay, Guanqi Hang, Yu Guang Tan, John S. P. Yuen, Melvin L. K. Chua, Rajan T. Gupta, Thomas J. Polascik, Nye Thane Ngo, and Yan Mee Law. “Corrigendum to "Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study" [Eur. J. Radiol. Open 11 (2023) 100529].” Eur J Radiol Open 12 (June 2024): 100556. https://doi.org/10.1016/j.ejro.2024.100556.
Velaga J, Tay KJ, Hang G, Tan YG, Yuen JSP, Chua MLK, et al. Corrigendum to "Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study" [Eur. J. Radiol. Open 11 (2023) 100529]. Eur J Radiol Open. 2024 Jun;12:100556.
Velaga, Jyothirmayi, et al. “Corrigendum to "Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study" [Eur. J. Radiol. Open 11 (2023) 100529].” Eur J Radiol Open, vol. 12, June 2024, p. 100556. Pubmed, doi:10.1016/j.ejro.2024.100556.
Velaga J, Tay KJ, Hang G, Tan YG, Yuen JSP, Chua MLK, Gupta RT, Polascik TJ, Ngo NT, Law YM. Corrigendum to "Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study" [Eur. J. Radiol. Open 11 (2023) 100529]. Eur J Radiol Open. 2024 Jun;12:100556.
Published In
Eur J Radiol Open
DOI
ISSN
2352-0477
Publication Date
June 2024
Volume
12
Start / End Page
100556
Location
England